KEMPHARM, INC·4

Jun 3, 8:55 PM ET

Mickle Travis C 4

4 · KEMPHARM, INC · Filed Jun 3, 2020

Insider Transaction Report

Form 4
Period: 2020-06-02
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2020-06-02$0.19/sh+110,000$20,7901,888,117 total
Holdings
  • Common Stock

    100,604
  • Common Stock

    (indirect: By Trust)
    21,466
  • Common Stock

    (indirect: By Trust)
    123,217
  • Common Stock

    (indirect: By Trust)
    243,880
  • Common Stock

    (indirect: By LLC)
    16,550
  • Common Stock

    (indirect: By Trust)
    157,197
Footnotes (2)
  • [F1]Held jointly with Christal M.M. Mickle.
  • [F2]The Reporting Person and Christal M.M. Mickle are the managing members of Mickle Investments, LLC.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4